Cellectis S.A.
Data quality: 17%
CLLS
Nasdaq
Manufacturing
Chemicals
$3.59
▲
$0.09
(2.57%)
Mkt Cap: 354.08 M
Price
$3.52
Mkt Cap
354.08 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—
Quick Summary
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current RatioN/A
Interest CoverageN/A
Valuation
P/E Ratio
N/A
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Price History
Peer Comparison
vs Manufacturing sector median (1366 peers)
Peer Comparison
vs Manufacturing sector median (1366 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | — | -1.5 |
| P/B | — | 1.6 |
| ROE % | — | -53.5 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
Analyst Price Target
4 analysts
Buy
Current
$3.59
Target
$7.25
$4.00
$7.50
$10.00
Forecast
Forward EPS
-$0.48
Est. Revenue
105.88 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2027 |
-$0.48
-$1.27 – $1.07
|
105.88 M | 4 |
| FY2026 |
-$0.90
-$0.98 – -$0.82
|
51.58 M | 5 |
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| 2026 Q2 |
-$0.26
-$0.34 – -$0.20
|
10.10 M | 5 |
| 2026 Q1 |
-$0.24
-$0.34 – -$0.20
|
8.71 M | 5 |
Earnings Surprises
Last 4 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| Q42025 | -$0.10 | -$0.24 | -140.0% |
| Q32025 | -$0.10 | $0.02 | +120.0% |
| Q22025 | -$0.15 | -$0.22 | -46.7% |
| Q12025 | $0.00 | -$0.17 | 0.0% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | N/A |
| ROE | N/A | ROA | N/A |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | N/A |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | N/A |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | N/A | Tangible Book Value | N/A |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | N/A | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | N/A | ||
| Market Cap | 354.08 M | Enterprise Value | N/A |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | N/A |
| FCF / Share | N/A | OCF / Share | N/A |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | N/A |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
{"event":"ticker_viewed","properties":{"ticker":"CLLS","listing_kind":"stock","pathname":"/stocks/clls","exchange":"Nasdaq","country":"US"}}